Three months after an FDA approval for cancer immunotherapy Unloxcyt, Checkpoint Therapeutics has found a buyer. | Three ...

India's Sun Pharmaceutical Industries said on Monday it will acquire Checkpoint Therapeutics , a U.S.-based immunotherapy and targeted oncology company, for $355 million.

Shares of Checkpoint Therapeutics surged in premarktet trading Monday after the immunotherapy and targeted oncology company agreed to be acquired by Indian pharmaceutical giant Sun Pharmaceutical ...

LOUISVILLE, Ky. (AP) — LOUISVILLE, Ky. (AP) — Turning Point Brands, Inc. (TPB) on Thursday reported profit of $2.4 million in its fourth quarter. The Louisville, Kentucky-based company said it ...

Revenue: US$360.7m (down 11% from FY 2023). Net income: US$47.3m (up 23% from FY 2023). Profit margin: 13% (up from 9.5% in FY 2023). The increase in margin was driven by lower expenses. EPS: US$2 ...

(RTTNews) - Turning Point Brands. Inc (TPB) released earnings for fourth quarter that decreased from last year but beat the Street estimates. The company's earnings totaled $2.42 million ...

At this time, I would like to welcome everyone to the Turning Point Brands’ Fourth Quarter and Fiscal Year 2024 Conference Call. All lines have been placed on mute to prevent any background noise.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Try Now>> See Insiders’ Hot Stocks on TipRanks >> Read More on TPB: Turning Point Brands NewsMORE Related Stocks Indices Commodities Currencies Stocks ...

Alliance Global Partners raised the firm’s price target on Turning Point Brands (TPB) to $85 from $80 and keeps a Buy rating on the shares. The company’s Q4 print came in at the high-end of ...